US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist

20.990
-0.030-0.14%

Close Jul 26 16:00 ET

20.990
0.0000.00%

Post 20:02 ET

979.39MMarket Cap-17683P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

9.07%12.41M

44.99%25.38M

-55.95%2.1M

-17.00%2.8M

149.90%9.1M

98.78%11.37M

40.97%17.5M

39.57%4.77M

6.81%3.37M

34.88%3.64M

Operating revenue

9.07%12.41M

44.99%25.38M

-55.95%2.1M

-17.00%2.8M

149.90%9.1M

98.78%11.37M

40.97%17.5M

39.57%4.77M

6.81%3.37M

34.88%3.64M

Cost of revenue

-51.19%2.21M

-5.17%10.32M

-65.12%1.35M

-32.87%1.61M

20.37%2.83M

99.30%4.53M

45.92%10.88M

88.98%3.86M

16.67%2.39M

28.88%2.35M

Gross profit

49.02%10.19M

127.41%15.06M

-16.89%753K

21.90%1.19M

385.90%6.27M

98.43%6.84M

33.51%6.62M

-33.97%906K

-11.50%977K

47.37%1.29M

Operating expense

-24.44%14.35M

17.11%64.66M

18.41%14.05M

-4.85%13.89M

15.28%17.73M

42.04%18.99M

8.75%55.21M

-6.08%11.87M

9.04%14.6M

11.43%15.38M

Selling and administrative expenses

-19.84%5.17M

5.24%20.64M

18.66%4.12M

-14.95%4.96M

12.47%5.12M

11.86%6.45M

-1.99%19.61M

-35.91%3.47M

6.49%5.83M

-15.42%4.55M

-General and administrative expense

-19.84%5.17M

5.24%20.64M

18.66%4.12M

-14.95%4.96M

12.47%5.12M

11.86%6.45M

-1.99%19.61M

-35.91%3.47M

6.49%5.83M

-15.42%4.55M

Research and development costs

-26.80%9.18M

23.65%44.03M

18.31%9.94M

1.86%8.93M

16.46%12.62M

64.92%12.54M

15.73%35.61M

16.27%8.4M

10.80%8.77M

32.63%10.83M

Operating profit

65.79%-4.16M

-2.08%-49.6M

-21.33%-13.3M

6.77%-12.7M

18.68%-11.46M

-22.45%-12.15M

-6.07%-48.59M

2.68%-10.96M

-10.88%-13.62M

-8.99%-14.09M

Net non-operating interest income expense

250.95%791K

688.83%1.41M

108.78%451K

-52.55%2.04M

-182.66%-553K

-249.71%-524K

8,850.00%179K

-6,518.75%-5.14M

1,751.29%4.3M

205.48%669K

Non-operating interest income

139.29%804K

539.82%1.45M

107.58%388K

-52.74%2.05M

-49.18%340K

-4.00%336K

2,160.00%226K

-256,200.00%-5.12M

1,362.50%4.33M

205.48%669K

Non-operating interest expense

-98.49%13K

-27.66%34K

-584.62%-63K

-76.47%8K

--893K

--860K

487.50%47K

116.67%13K

-46.88%34K

--0

Other net income (expense)

-302.49%-2.12M

2,477.27%1.05M

Gain on sale of security

----

-302.49%-2.12M

----

2,477.27%1.05M

----

Income before tax

73.45%-3.37M

-6.21%-50.31M

0.56%-14.97M

-14.31%-10.66M

10.51%-12.01M

-32.40%-12.67M

-3.30%-47.37M

-34.05%-15.05M

22.62%-9.33M

-5.60%-13.42M

Income tax

39.69%-1.49M

-2.38%-7.04M

56.95%-554K

-8.46%-2.41M

-8.64%-1.61M

-30.77%-2.47M

-6.72%-6.88M

28.22%-1.29M

-4.71%-2.22M

-37.13%-1.48M

Net income

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

28.46%-7.1M

-2.67%-11.94M

Net income continuous Operations

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

28.46%-7.1M

-2.67%-11.94M

Minority interest income

Net income attributable to the parent company

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

28.46%-7.1M

-2.67%-11.94M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

81.62%-1.88M

-6.86%-43.27M

-4.72%-14.41M

-16.15%-8.25M

12.88%-10.4M

-32.80%-10.2M

-2.74%-40.49M

-45.89%-13.76M

28.46%-7.1M

-2.67%-11.94M

Basic earnings per share

85.26%-0.042

7.16%-1.167

4.58%-0.375

-2.78%-0.222

27.82%-0.288

-10.47%-0.285

5.42%-1.257

-24.76%-0.393

35.14%-0.216

-1.53%-0.399

Diluted earnings per share

85.26%-0.042

7.16%-1.167

4.58%-0.375

-2.78%-0.222

27.82%-0.288

-10.47%-0.285

5.42%-1.257

-24.76%-0.393

35.14%-0.216

-1.53%-0.399

Dividend per share

Currency Unit

GBP

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	9.07%12.41M	44.99%25.38M	-55.95%2.1M	-17.00%2.8M	149.90%9.1M	98.78%11.37M	40.97%17.5M	39.57%4.77M	6.81%3.37M	34.88%3.64M
Operating revenue	9.07%12.41M	44.99%25.38M	-55.95%2.1M	-17.00%2.8M	149.90%9.1M	98.78%11.37M	40.97%17.5M	39.57%4.77M	6.81%3.37M	34.88%3.64M
Cost of revenue	-51.19%2.21M	-5.17%10.32M	-65.12%1.35M	-32.87%1.61M	20.37%2.83M	99.30%4.53M	45.92%10.88M	88.98%3.86M	16.67%2.39M	28.88%2.35M
Gross profit	49.02%10.19M	127.41%15.06M	-16.89%753K	21.90%1.19M	385.90%6.27M	98.43%6.84M	33.51%6.62M	-33.97%906K	-11.50%977K	47.37%1.29M
Operating expense	-24.44%14.35M	17.11%64.66M	18.41%14.05M	-4.85%13.89M	15.28%17.73M	42.04%18.99M	8.75%55.21M	-6.08%11.87M	9.04%14.6M	11.43%15.38M
Selling and administrative expenses	-19.84%5.17M	5.24%20.64M	18.66%4.12M	-14.95%4.96M	12.47%5.12M	11.86%6.45M	-1.99%19.61M	-35.91%3.47M	6.49%5.83M	-15.42%4.55M
-General and administrative expense	-19.84%5.17M	5.24%20.64M	18.66%4.12M	-14.95%4.96M	12.47%5.12M	11.86%6.45M	-1.99%19.61M	-35.91%3.47M	6.49%5.83M	-15.42%4.55M
Research and development costs	-26.80%9.18M	23.65%44.03M	18.31%9.94M	1.86%8.93M	16.46%12.62M	64.92%12.54M	15.73%35.61M	16.27%8.4M	10.80%8.77M	32.63%10.83M
Operating profit	65.79%-4.16M	-2.08%-49.6M	-21.33%-13.3M	6.77%-12.7M	18.68%-11.46M	-22.45%-12.15M	-6.07%-48.59M	2.68%-10.96M	-10.88%-13.62M	-8.99%-14.09M
Net non-operating interest income expense	250.95%791K	688.83%1.41M	108.78%451K	-52.55%2.04M	-182.66%-553K	-249.71%-524K	8,850.00%179K	-6,518.75%-5.14M	1,751.29%4.3M	205.48%669K
Non-operating interest income	139.29%804K	539.82%1.45M	107.58%388K	-52.74%2.05M	-49.18%340K	-4.00%336K	2,160.00%226K	-256,200.00%-5.12M	1,362.50%4.33M	205.48%669K
Non-operating interest expense	-98.49%13K	-27.66%34K	-584.62%-63K	-76.47%8K	--893K	--860K	487.50%47K	116.67%13K	-46.88%34K	--0
Other net income (expense)		-302.49%-2.12M					2,477.27%1.05M
Gain on sale of security	----	-302.49%-2.12M	----	----	----	----	2,477.27%1.05M	----	----	----
Income before tax	73.45%-3.37M	-6.21%-50.31M	0.56%-14.97M	-14.31%-10.66M	10.51%-12.01M	-32.40%-12.67M	-3.30%-47.37M	-34.05%-15.05M	22.62%-9.33M	-5.60%-13.42M
Income tax	39.69%-1.49M	-2.38%-7.04M	56.95%-554K	-8.46%-2.41M	-8.64%-1.61M	-30.77%-2.47M	-6.72%-6.88M	28.22%-1.29M	-4.71%-2.22M	-37.13%-1.48M
Net income	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M	28.46%-7.1M	-2.67%-11.94M
Net income continuous Operations	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M	28.46%-7.1M	-2.67%-11.94M
Minority interest income
Net income attributable to the parent company	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M	28.46%-7.1M	-2.67%-11.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	81.62%-1.88M	-6.86%-43.27M	-4.72%-14.41M	-16.15%-8.25M	12.88%-10.4M	-32.80%-10.2M	-2.74%-40.49M	-45.89%-13.76M	28.46%-7.1M	-2.67%-11.94M
Basic earnings per share	85.26%-0.042	7.16%-1.167	4.58%-0.375	-2.78%-0.222	27.82%-0.288	-10.47%-0.285	5.42%-1.257	-24.76%-0.393	35.14%-0.216	-1.53%-0.399
Diluted earnings per share	85.26%-0.042	7.16%-1.167	4.58%-0.375	-2.78%-0.222	27.82%-0.288	-10.47%-0.285	5.42%-1.257	-24.76%-0.393	35.14%-0.216	-1.53%-0.399
Dividend per share
Currency Unit	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall